Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Occurrence Rate of Non-Small Cell Lung, Colon Cancer, Breast Cancer, Gastric Cancer and Malignant Melanoma in Turkey & Diagnosis and Treatment Characteristics Turkish "Non-Small Cell Lung-Colon-Gastric-Breast (CGB) Cancer and Malignant Melanoma" Study

NCT01775514 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT01775514
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01775514 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Occurrence Rate of Non-Small Cell Lung, Colon Cancer, Breast Cancer, Gastric Cancer and Malignant Melanoma in Turkey & Diagnosis and Treatment Characteristics Turkish "Non-Small Cell Lung-Colon-Gastric-Breast (CGB) Cancer and Malignant Melanoma" Study
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
October 31, 2012
Completion date
October 31, 2015
Enrollment
32,277 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

cancer